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Abstracts / Urological Science 26 (2015) S36eS49 S45downstream of a luciferase gene, and luciferase reporter assays were
performed to verify the direct binding of miR-99a to mTOR transcripts.
The mRNA and protein expression level of mTOR were measured by Q-
PCR and Western blot, respectively. Cell viability of miR-99a transfected
cells was detected by WST-1 and colony formation assays. Inhibition of
mTOR complex 1 and 2 (mTORC1 and mTORC2) signaling was moni-
tored by detecting the phosphorylation of S6K and Akt using Western
blot. Induction of autophagy was accessed by the expression of LC3-II
marker protein.
Results: Transfection of miR-99a expressing vector elevated the
expression level of miR-99a up to 4.5-fold in cells compared to vector-
only control. The function of matured miR-99a was conﬁrmed by
luciferase reporter assays. The level of mTOR RNA and protein were
decreased in miR-99a transfected cells. Dual inhibition of mTORC1 and
mTORC2 was conﬁrmed by immunoprecipitation (IP) of mTOR associ-
ated Rictor and Raptor, and the decreased phosphorylation of S6K and
Akt in miR-99a transfected cells. The LC3-II protein was accumulated in
miR-99a transfected cells compared to monk transfected control, sug-
gesting that inhibition of mTOR by miR-99a induces autophagy in
bladder cancer cells.
Conclusions: This is the ﬁrst study showed that miR-99a markedly in-
hibits bladder cancer cell growth via dual inhibition of mTORC1 and
mTORC2. miR-99a treatment also induces autophagy through mTOR in-
hibition. However, the role of miR-99a induces autophagy remains further
investigation.
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BLUE-LIGHT EXPOSURE ACCELERATES PHOTO-OXIDATIVE DISRUPTION
OF LYSOSOMAL MEMBRANES AND APOPTOSIS IN ACRIDINE ORANGE-
LOADED CHLOROQUINE-TREATED HUMAN BLADDER CANCER CELLS
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Introduction: We previously showed that human bladder cancer cells
exhibited high basal level of autophagic activity. Administration of chlo-
roquine (CQ) or hydroxychloroquine (HCQ) inhibits autophagy and causes
apoptotic cell death in bladder cancer cells. Acridione orange (AO) is
commonly used to identify acidic vescular organelles (AVOs) in autophagic
cells. The uncharged state of AO in cells was characterized by green ﬂuo-
rescence; while protonated form of AO accumulates in acidic compart-
ments and forms aggregates that characterized by red ﬂuorescence. An
incidentally found disruption of the lysosome under treatment of CQ and
blue light was observed. An experiment was conducted to verify the
phenomenon is meaningful.
Methods: Inhibition of basal autophagy was achieved using CQ inT24
human bladder cancer cell lines by detecting LC3-II formation. Acridine
orange relocalization was performed in T24 cells with or without CQ
treatment for 2 hours. Immunoﬂuorescence and Western blot were used
for detection of cathepsin B and D release from lysosome. Cell viability and
induction of cell death were detected using ApoTox-Glo Triplex Assay kit
from Promega.
Results: CQ inhibited basal autophagy and decreased cell viability in T24
cells. AO relocalization was detected only in CQ-treated T24 cells. CQ-
treated T24 cells that exposed for a short period of time to AO and under
ordinary culture condition, accumulate the AOwithin AVOs, giving rise to a
mainly red, granular ﬂuorescence upon excitation with blue light. When
AO-loaded CQ-treated cells are irradiated with intense blue light, AO soon
starts to leak from lysosomes to nuclear and cytosol diffusely. Severe
lysosomal damage that causing necrosis and apoptosis was only detected
in AO-loaded CQ-treated T24 cells. This photo-oxidative disruption of
lysosome was responsible for triggering cell death in bladder cancer cells.
Necrotic and apoptotic death were both detected in cell treated with CQ up
to 50%.
Conclusions: Photo-oxidative disruption of lysosomal membrane with
AO and CQ may be an effective cancer therapy in human bladder
cancer.MP4-5.
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Purpose: To report our preliminary experience regarding the application
of SPICE technology in the diagnosis and treatment of bladder urothelial
carcinoma.
Patients and methods: A prospective randomized trial will be conducted
from January 2015 to May 2015. A total of 30 patients with bladder uro-
thelial carcinoma will be enrolled into this study. All patients received
standard cystoscopy followed by SPICE technology cystoscopy. The num-
ber of tumor was counted under direct vision by two experienced urolo-
gists. All patients received transurethral resection of bladder tumor. All
patients received standard treatment protocol and followed every 3
months using standard cystoscopy.
Results: The number of tumor diagnosed under standard cystoscopy or
SPICE technology cystoscopy will be compared in this study. The incidence
of tumor recurrence and metastasis will be calculated in this study.
Conclusion: Cystoscopy empowered with SPICE technology will be a
viable option to assist the diagnosis and treatment of bladder urothelial
carcinoma.
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TOLL-LIKE RECEPTOR 6 AND CONNECTIVE TISSUE GROWTH FACTOR
ARE SIGNIFICANTLY UPREGULATED IN MITOMYCIN-C-TREATED
UROTHELIAL CARCINOMA CELLS UNDER HYDROSTATIC PRESSURE
STIMULATION
Shao Kuan Chen. Sijhih Cathay General Hospital, Taiwan
Purpose: Urothelial carcinoma (UC) is the most common histologic sub-
type of bladder cancer. The administration of mitomycin C (MMC) into
bladder after transurethral resection of the bladder tumor (TURBT) is a
common treatment strategy for preventing recurrence after surgery. We
previously applied hydrostatic pressure combined with MMC in UC cells
and found that hydrostatic pressure synergistically enhanced MMC-
induced UC cell apoptosis via the Fas/FasL pathways.
Materials and methods: To understand the alteration of gene expressions
in UC cells caused by hydrostatic pressure and MMC, oligonucleotide
microarray was used to explore all of the differentially expressed genes.
Results: After bioinformatics analysis and gene annotation, toll-like re-
ceptor 6 (TLR6) and connective tissue growth factor (CTGF) showed sig-
niﬁcant up-regulation among altered genes, and their gene and protein
expressions with each treatment of UC cells were validated by quantitative
real-time PCR and immunoblotting.
Conclusion: Under treatment with MMC and hydrostatic pressure, UC
cells showed increasing apoptosis via extrinsic pathways through upre-
gulation of TLR6 and CTGF.
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CLINICAL OUTCOMES IN CASTRATION RESISTANT PROSTATE CANCER
PATIENTS TREATING WITH CABAZITAXEL
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Purpose: The aim of this study was to assess the clinical outcomes of
Cabazitaxel in treating castration resistant prostate cancer patients in
Taichung Veterans General Hospital.
Materials and methods: From Aug 2011 to Dec 2014, thirty-two patients
with castration resistant prostate cancer were treated with Cabazitaxel 20-
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docetaxel treatments. The PSA response, pain response, time to progres-
sion duration and adverse events were recorded.
Results: The median age of the thirty-two patients was 65.7 years (range
45e84) and the median PSA when started Cabazitaxel was 65.5 ng/ml
(range 3.82e5239). The mean treatment courses of the patient were 5.9
(range 3e17). PSA declined in twenty-two patients (69%, 22/32) and
eighteen of them (56%, 18/32) got more than 50% declination (PSA
response). The median progression free survival was 6 months. The most
common subjective adverse effects were leukopenia (84%). Ten (31%) pa-
tients had grade 3-4 neutropenia and 4 (12.5%) patients had more than
grade 2 anemia. Liver function impairment was also found in three (9%)
patients.
Conclusions: Cabazitaxel 20-25mg/m2, IV, every three to four weeks were
tolerated and revealed good PSA response in castration resistant prostate
cancer patients. However, high risk of neutropenia should be kept in mind.
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Purpose: Androgen receptor (AR) plays a role in the development and
progression of upper urinary tract urothelial cell carcinoma (UUTUC). Here
we investigated whether AR stimulates UUTUC development and pro-
gression, possibly by expanding the population of cancer stem cells (CSCs),
which are a particular population of cells within cancer cells responsible
for tumor initiation, drug resistance and metastasis.
Materials and methods: We compared BFTC 909 cells with or without the
addition of AR on their CSC population with ﬂow cytometry, colony for-
mation and sphere formation assay to determine the effects of AR on CSC
activity. To observe the effects of AR on BFTC 909 cells, quantitative real-
time PCR was used to detect the expression stemness genes and miRNAs
and western blotting was also performed to examine EMT (epithelial-
mesenchymal transition) related proteins. In vivo tumor formation was
also evaluated with the implantation of cancer cells in nude mice and IHC
was used to detect OCT4 and MMP9 expression on the tumor samples.
Results: We found that the addition of AR in UUTUC cells, (BFTC 909 cell
line) signiﬁcantly increased the population of CSC, clonogenicity, sphere
formation and the expression of stemness genes (Oct4, Bmi1 and Nanog)
and CSC-related miRNA proﬁle as well as EMT related proteins. Further-
more, in an immune-deﬁcient mouse model, the addition of AR in UUTUC
cells also increased the tumor formation.
Conclusions: This study will help us better understand the extent to
which AR contributes to UUTUC by expanding their CSC population and
capacity and could explain high incidence of UUTUC observed in males.
These ﬁndings may lead AR to serve as a potential therapeutic target for
urothelial carcinomas in the future.
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RENAL CLASSIC AND EPITHELIOID ANGIOMYOLIPOMA e EXPERIENCE
OF CHI MEI HOSPITAL AND LITERATURES REVIEW
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Introduction: Renal angiomyolipoma (AML) is a benign neoplasm. There
are two major histologic types of AMLs: classic and epithelioid. Recently
malignant epithelioid variant of angiomyolipoma has been further
described. We would like to compare these two histologic types receiving
surgical treatment of our own experience
Material: We collected 53 cases of renal angiomyolipoma from our hos-
pital receiving surgical intervention from September 2010 to August 2014.
Results: Among these cases, 38 (71.7%) was female with medium age 56.9
year-old. 15 male (28.3%) with medium age 58.7 year-old. 21 of 53 (39.6%)had right side AML with left 30 of 53 (56.6%) and bilateral 1 of 53 (1.9%). 3
of 53 (5.7%) received nephrectomy and 50/53 (94.3%) received partial
nephrectomy. Classic angiomyolipoma accouted for 92.5% (49/53) of all
cases with epithelioid variant 7.5% (4/53). No recurrence was noticed
among classic type with average follow-up length 32.6 months. Recur-
rence was noted in one of epithelioid variant in 31 months follow-up.
Conclusion: Renal angiomyolipoma is a benign neoplasm consisting of
thick-walled aneurysmal vessels, smooth muscle, and varying levels of
mature adipose tissue. Recently malignant epithelioid variant of angio-
myolipoma has been further described since it was presented on 1997 by
Eble and colleagues. Here, We compared these two histologic types
receiving surgical treatment of our own experience and we would like to
compared it with data of other institute to see of there’s any differences
and the cause leading to it.
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Purpose: Retroperitoneal liposarcomas are rare malignant tumor with an
aggressive disease course and high recurrent rate. In this article, we will
share our experience in treating retroperitoneal liposarcoma and describe
the tumor behavior we observed.
Materials and methods: During January 2010 to December 2014, 11 pa-
tient are treated in our hospital for retroperitoneal liposarcomas. We re-
view the treatments (surgical or non-surgical), clinical presentation, tumor
behavior, pathological subtype, and the characteristics of recurrent tumor.
Results: There are 11 patients of retroperitoneal liposarcoma enrolled in
this analysis. 9 patients are female, and 2 are male. 7 patients are well-
differentiated liposarcoma, and 4 are de-differentiated liposarcoma. One
patient died one month after surgical excision of tumor because of
pneumonia. One patient has no recurrence in 3 years of follow-up. One has
bone metastasis at the time of diagnosis. 8 patients are found recurrent
and receive repeated surgical excision of tumor, and 3 of them experience
second recurrence. One patient experience third recurrence, and one has
forth recurrence. The mean time to recurrence is 40 months. 4 patients
have surgical margin involved with tumor, and the mean recurrence time
in this subgroup is 5 months.
Conclusions: During the past 4 years, 11 patients with retroperitoneal
liposarcoma receiving surgical excision of tumor have been followed at our
hospital. There is no obvious difference in tumor recurrence between pa-
thology subtypes. Patients with positive surgical margin experience
shorter time to recurrence.Moderated Poster-5Oncology
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THE INFLUENCE OF INTRAVESICAL PROSTATIC PROTRUSION AND POST
OPERATIVE CONTINENCE AFTER PATIENTS RECEIVED ROBOTIC
ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY
Sheng-Chun Hung, Yen-Chuan Ou PhD, Cheng-Kuang Yang. Divisions of
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Purpose: We try to evaluate the inﬂuence of intravesical prostatic pro-
trusion (IPP) in the postoperative continence of patient who received ro-
botic assisted laparoscopic radical prostatectomy.
Materials and methods: A total 600 patients who underwent robotic
assisted laparoscopic radical prostatectomy were included in the study.
Preoperative MRI was performed in all patients and the vertical distance
from the tip of the protruding prostate to the base of the urinary bladder
was measured in all sagittal plane. The degree of intravesical prostatic
protrusion were divided into three groups ( IPP<5mm, 5mm<IPP<10mm,
